TY - JOUR T1 - Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia JF - medRxiv DO - 10.1101/19012203 SP - 19012203 AU - Kamen A. Tsvetanov AU - Stefano Gazzina AU - Simon P. Jones AU - John van Swieten AU - Barbara Borroni AU - Raquel Sanchez-Valle AU - Fermin Moreno AU - Robert Laforce, Jr AU - Caroline Graff AU - Matthis Synofzik AU - Daniela Galimberti AU - Mario Masellis AU - Maria Carmela Tartaglia AU - Elizabeth Finger AU - Rik Vandenberghe AU - Alexandre de Mendonça AU - Fabrizio Tagliavini AU - Isabel Santana AU - Simon Ducharme AU - Chris Butler AU - Alex Gerhard AU - Adrian Danek AU - Johannes Levin AU - Markus Otto AU - Giovanni Frisoni AU - Roberta Ghidoni AU - Sandro Sorbi AU - Jonathan D. Rohrer AU - James B. Rowe AU - on behalf of the Genetic FTD Initiative, GENFI Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/11/22/19012203.abstract N2 - INTRODUCTION The presymptomatic phase of neurodegenerative disease can last many years, with sustained cognitive function despite progressive atrophy. We investigate this phenomenon in familial Frontotemporal dementia (FTD).METHODS We studied 121 presymptomatic FTD mutation carriers and 134 family members without mutations, using multivariate data-driven approach to link cognitive performance with both structural and functional magnetic resonance imaging. Atrophy and brain network connectivity were compared between groups, in relation to the time from expected symptom onset.RESULTS There were group differences in brain structure and function, in the absence of differences in cognitive performance. Specifically, we identified behaviourally-relevant structural and functional network differences. Structure-function relationships were similar in both groups, but coupling between functional connectivity and cognition was stronger for carriers than for non-carriers, and increased with proximity to the expected onset of disease.DISCUSSION Our findings suggest that maintenance of functional network connectivity enables carriers to maintain cognitive performance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKamen A. Tsvetanov is supported by the British Academy (Postdoctoral Fellowship, PF160048). James B Rowe is supported by the Wellcome Trust (103838) the Medical Research Council (SUAG/051 G101400) and the Cambridge NIHR Biomedical Research Centre. Raquel Sánchez-Valle is supported by the Instituto de Salud Carlos III and the JPND network PreFrontAls (01ED1512/AC14/0013) and the Fundació Marató de TV3 (20143810).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData access and sharing are subject to consent and GENFI consortium oversight. For enquires regarding data access please contact the senior author in the first instance. ER -